RELATED PARTY TRANSACTION(S) WITH AMINOVA INFUSIONS PVT LTD
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Beryl Drugs Ltd has received shareholder approval at its Extra-Ordinary General Meeting held on 11th May 2026 for a material related party transaction with Aminova Infusions Pvt Ltd. The transaction involves appointing Aminova as a distributor for Beryl Drugs' PP Bottle and FFS products in markets like Maharashtra and Gujarat, and for exports. The value is Rs. 5 crore, representing approximately 13.30% of the company's annual consolidated turnover. The agreement runs from 3rd January 2026, with Mr. Shailendra Pathak (a Whole-Time Director of Beryl Drugs) being the Promoter of Aminova. The transaction is on an arm's length basis and in the ordinary course of business. The Audit Committee had earlier reviewed and approved the transaction on 3rd January 2026.
This is a routine related party transaction for distribution expansion. The deal enables Beryl Drugs to leverage the pharmaceutical expertise of Mr. Shailendra Pathak to access new markets. Given it's already approved by shareholders and on arm's length terms, the market impact should be minimal unless investors view the related party angle negatively.